|
Mar 10
|
Sector Update: Health Care Stocks Decline Late Afternoon
|
|
Mar 10
|
Update: Checkpoint Therapeutics to Be Acquired by India's Sun Pharmaceutical -- Checkpoint Shares Jump Monday
|
|
Mar 10
|
India-Based Sun Pharma To Buy US Cancer Firm Checkpoint Therapeutics: Details
|
|
Mar 10
|
Top India Drugmaker to Buy US-Based Checkpoint for $355 Million
|
|
Mar 10
|
Sun Pharma agrees to acquire Checkpoint Therapeutics
|
|
Mar 10
|
India’s Sun Pharma to buy Checkpoint Therapeutics for $355 mln
|
|
Mar 10
|
India's Sun Pharma to acquire Checkpoint Therapeutics for $355 million
|
|
Mar 10
|
Sun Pharma to Acquire Checkpoint Therapeutics
|
|
Jul 25
|
Checkpoint Therapeutics Announces FDA Acceptance of BLA Resubmission of Cosibelimab for the Treatment of Advanced Cutaneous Squamous Cell Carcinoma
|
|
Jul 2
|
Checkpoint Therapeutics Resubmits Biologics License Application for Cosibelimab, Launches $12 Million Direct Share Offering
|
|
Jul 2
|
Checkpoint Therapeutics Announces $12 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
|
|
Jul 2
|
Checkpoint Therapeutics Announces Biologics License Application Resubmission for Cosibelimab
|
|
Jun 24
|
Checkpoint Therapeutics Announces Alignment with FDA Enabling Upcoming Cosibelimab BLA Resubmission
|
|
May 13
|
Checkpoint Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference
|
|
May 12
|
Checkpoint Therapeutics First Quarter 2024 Earnings: US$0.32 loss per share (vs US$0.89 loss in 1Q 2023)
|
|
May 10
|
Checkpoint Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Updates
|
|
Mar 24
|
Checkpoint Therapeutics Full Year 2023 Earnings: Misses Expectations
|
|
Mar 22
|
Checkpoint Therapeutics Reports Full-Year 2023 Financial Results and Recent Corporate Highlights
|
|
Mar 18
|
Checkpoint Therapeutics Announces Appointment of Accomplished Life Sciences Executive Amit Sharma, M.D. to Board of Directors
|
|
Jan 11
|
Checkpoint Therapeutics to Participate in the B. Riley Securities 4th Annual Oncology Conference
|